Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-03-28NKG2D CAR-NK Cell Therapy for Patients With Platinum-Resistant Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-03-27Phase III Randomized Multicentre Trial of Carboplatin + Liposomal Doxorubicin vs Carboplatin + Paclitaxel in Patients With Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-03-24Open-label Phase II Trial of Adjuvant bishRNAfurin and GMCSF Augmented Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-03-24MITO 35a: A Multicenter, Prospective, Single Arm Trial of Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wildtype Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2023-03-24A MULTICENTER STUDY IN PATIENTS WITH STAGE III-IV EPITHELIAL OVARIAN CANCER TREATED WITH CARBOPLATIN/PACLITAXEL WITH BEVACIZUMAB: CLINICAL AND BIOLOGICAL PROGNOSTIC FACTORS
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-03-243D-PREDICT REGISTRY: 3D Prediction of Patient-specific Response Using Ex Vivo Interrogation of Live Cells From Tumors
-
CLINICAL_TRIALS study record update · 2023-03-24Weekly Versus Every 3 Week Carboplatin and Paclitaxel in Patients With Ovarian Cancer: a Phase III Randomized Multicenter Study
-
CLINICAL_TRIALS study record update · 2023-03-24A Phase II Clinical Trial of Pembrolizumab in Combination With Carboplatin-paclitaxel in Patients With Advanced (Stage III B-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer: MITO28/MANGO OV4 Study
-
CLINICAL_TRIALS study record update · 2023-03-24Pathway to Diagnosis of Ovarian Cancer: Observational Retrospective Multicenter Study
-
CLINICAL_TRIALS study record update · 2023-03-24Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients. The Phase III Randomized, Open Label MITO 35b Study: a Project of the MITO-MANGO Groups.
-
CLINICAL_TRIALS study record update · 2023-03-20Pre-Surgical Window Pilot Investigation of the Effect of PARP Inhibition on the Cellular and Molecular Changes in Primary Ovarian and Breast Cancer
-
CLINICAL_TRIALS study record update · 2023-03-20Development and Validation of a Blood Test for Screening and Early Detection of Multiple Cancers Based on Circulating Cell-free Nucleic Acid Profiles - Project CADENCE (CAncer Detected Early caN be CurEd)
-
CLINICAL_TRIALS study record update · 2023-03-17A Phase III Trial of Carboplatin and Paclitaxel Plus Placebo Versus Carboplatin Paclitaxel Plus Concurrent and Extended Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated, Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2023-03-14Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-03-07MELISA Trial: Mapping sEntinel Lymph Node in Initial StAges of Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-03-01Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-02-28Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-02-23Guangzhou Women's Health Cohort Study (GWHCS)
-
CLINICAL_TRIALS study record update · 2023-02-22Open Label Phase II Clinical Trial of Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GreKo III Study
-
CLINICAL_TRIALS study record update · 2023-02-17The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2023-02-17A Phase III, Multicenter, Randomized, Study of Atezolizumab Versus Placebo Administered in Combination With Paclitaxel, Carboplatin, and Bevacizumab to Patients With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2023-02-13A Phase 1b/2 Randomized, Controlled Study of AVB-S6-500 in Combination With Pegylated Liposomal Doxorubicin (PLD) or Paclitaxel (Pac) in Patients With Platinum-resistant Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-02-06Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
-
CLINICAL_TRIALS study record update · 2023-02-03Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125
-
CLINICAL_TRIALS study record update · 2023-01-31A Phase 2, Multicenter, Open-Label Basket Study of Navicixizumab Monotherapy or in Combination With Paclitaxel or Irinotecan in Patients With Select Advanced Solid Tumors